Auf dieser Seite
01BDX Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
BDX Becton, Dickinson and Company Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$176,80
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$127,5952-Wochen-Tief
$193,0752-Wochen-Hoch
P/E (TTM)
53.4
EPS (TTM)
$3.31
Umsatz (TTM)
$20.84B
Ihre Abzeichen
52W-Spanne
$128–$193
Analystenbewertung
HOLD
Kursziel
$196
P/E
53.4
ROE
3.8%
Nettogewinnmarge
4.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
BDX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$176.80
P/E (TTM)
53.4
EPS (TTM)
$3.31
Umsatz (TTM)
$20.84B
ROE (TTM)
3.8%
Verschuldungsgrad (MRQ)
0.6
52W-Spanne
$128–$193
BDX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 10. Februar 2026 | 159-for-125 | Vorwärts |
| 1. April 2022 | 41-for-40 | Vorwärts |
| 21. August 1998 | 2-for-1 | Vorwärts |
| 16. August 1996 | 2-for-1 | Vorwärts |
| 1. März 1993 | 2-for-1 | Vorwärts |
| 3. März 1986 | 2-for-1 | Vorwärts |
Über Becton, Dickinson and Company Common Stock Unternehmensübersicht von Wikipedia
BD (Becton, Dickinson and Company) ist eines der größten internationalen Medizintechnologie-Unternehmen. Es entwickelt, produziert und vertreibt medizinische Einmalartikel, Gerätesysteme und Reagenzien. BD versorgt Krankenhäuser, Gesundheitseinrichtungen, Biowissenschaftler, klinische Labore und die pharmazeutische Industrie. BD ist weltweit in drei Segmente gegliedert: BD Medical, BD Life Sciences und BD Interventional.
Das Unternehmen ist am New York Stock Exchange und im S&P 500 Index gelistet. In der Fortune 500 Liste von 2022 belegt BD Platz 173.
Geschichte und Entwicklung
Dickinson and Company wurde 1897 von Maxwell W. Becton und Fairleigh S. Dickinson in den USA gegründet. Heute ist das Unternehmen in über 190 Ländern tätig.
Im Jahr 2014 vereinbarte BD den Erwerb des Unternehmens CareFusion und 2017 wurde das Unternehmen C. R. Bard übernommen.
Im Januar 2020 wurde Thomas Polen zum CEO und Präsident von BD und zum Nachfolger von Vincent Forlenza.
BD in Deutschland, Österreich und der Schweiz
An 10 Standorten in Deutschland, Österreich und der Schweiz beschäftigt BD mehr als 2500 Mitarbeiter.
Deutschland
2011 wurde am Standort Heidelberg das neue Gebäude eingeweiht, das nach LEED-Gold-Standard zertifiziert wurde. Das 23 Mio. Euro teure Green Building beherbergt Labore, Büro- und Seminarräume.
Österreich
In Österreich ist BD an zwei Standorten vertreten. Während am Standort Millennium Tower vorwiegend F&E für die Geschäftsbereiche Medication Management Solutions (MMS) betrieben wird, gilt der Standort Rinnböckstrasse als Standort für Vertriebstätigkeiten aller anderen Geschäftsbereiche. In Österreich sind circa 200 Personen bei BD angestellt.
Schweiz
BD ist in der Schweiz an drei Standorten vertreten. In Eysins befindet sich der europäische Hauptsitz des Unternehmens. In Allschwil sind die BD-Segmente Medical und Biosciences angesiedelt. Am Standort Wangs entwickelt und produziert die Straub Medical AG, die seit Frühjahr 2020 zu BD gehört, Medizinprodukte zur Behandlung von Durchblutungsstörungen.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter72.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$21.84B2016-09-30 → 2025-09-30
EPS$5.822016-09-30 → 2025-09-30
Freier Cashflow$2.67B2016-09-30 → 2025-09-30
Nettogewinnmarge4.5%2016-09-30 → 2025-09-30
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | BDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 53.45-Jahres-Durchschnitt ≈31.2 | ≈31.2 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈3.2 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | BDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 9.6%5-Jahres-Durchschnitt ≈12.1% | ≈12.1% | · | · | |
| EBITDA-Marge (TTM) | 21.0%5-Jahres-Durchschnitt ≈23.6% | ≈23.6% | · | · | |
| Vorgewinnmarge (TTM) | 7.2%5-Jahres-Durchschnitt ≈9.5% | ≈9.5% | · | · | |
| Nettogewinnmarge (TTM) | 4.5%5-Jahres-Durchschnitt ≈8.7% | ≈8.7% | · | · | |
| ROA (TTM) | 1.8%5-Jahres-Durchschnitt ≈3.2% | ≈3.2% | · | · | |
| ROE (TTM) | 3.8%5-Jahres-Durchschnitt ≈7.0% | ≈7.0% | · | · | |
| ROIC | 5.3%5-Jahres-Durchschnitt ≈5.3% | ≈5.3% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | BDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Liquiditätsgrad (MRQ) | 0.95-Jahres-Durchschnitt ≈1.2 | ≈1.2 | · | · | |
| Quick Ratio | 0.45-Jahres-Durchschnitt ≈0.5 | ≈0.5 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Interest Coverage (Zinsdeckungsgrad) | 4.25-Jahres-Durchschnitt ≈5.0 | ≈5.0 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | BDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 8.2%5-Jahres-Durchschnitt ≈6.5% | ≈6.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.0%5-Jahres-Durchschnitt ≈4.4% | ≈4.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 6.3% | · | · | · | |
| EPS YoY (EPS VjV) | -0.68%5-Jahres-Durchschnitt ≈28.1% | ≈28.1% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -1.6%5-Jahres-Durchschnitt ≈24.2% | ≈24.2% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -0.34%5-Jahres-Durchschnitt ≈5.6% | ≈5.6% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 16.5% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -1.9%5-Jahres-Durchschnitt ≈3.6% | ≈3.6% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 13.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | BDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · | |
| Inventory Turnover (Lagerumschlag) | 3.15-Jahres-Durchschnitt ≈3.4 | ≈3.4 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 7.25-Jahres-Durchschnitt ≈7.9 | ≈7.9 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$303.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Ausschüttungsquote71.3%
Annualisierte Auszahlung≈$4.20
5J Div CAGR≈6.2%
Wachstumsphase≈41
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Sep 9, 2026 | $1,05 | USD | ≈2.2% |
| Jun 9, 2026 | $1,05 | USD | ≈2.5% |
| Mär 10, 2026 | $1,05 | USD | ≈2.1% |
| Dez 8, 2025 | $0,83 | USD | ≈2.2% |
| Sep 8, 2025 | $0,82 | USD | ≈2.2% |
| Jun 9, 2025 | $0,82 | USD | ≈2.4% |
| Mär 10, 2025 | $0,82 | USD | ≈1.7% |
| Dez 9, 2024 | $0,82 | USD | ≈1.7% |
| Sep 9, 2024 | $0,75 | USD | ≈1.6% |
| Jun 10, 2024 | $0,75 | USD | ≈1.6% |
| Mär 7, 2024 | $0,75 | USD | ≈1.6% |
| Dez 7, 2023 | $0,75 | USD | ≈1.6% |
| Sep 7, 2023 | $0,72 | USD | ≈1.4% |
| Jun 8, 2023 | $0,72 | USD | ≈1.4% |
| Mär 9, 2023 | $0,72 | USD | ≈1.5% |
| Dez 8, 2022 | $0,72 | USD | ≈1.4% |
| Sep 8, 2022 | $0,68 | USD | ≈1.3% |
| Jun 8, 2022 | $0,68 | USD | ≈1.3% |
| Mär 9, 2022 | $0,67 | USD | ≈1.3% |
| Dez 9, 2021 | $0,67 | USD | ≈1.4% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2.7%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $3.23 | $3.17 | 1.8% | |
| 31. März 2026 | $2.90 | $2.80 | 3.5% | |
| 31. Dezember 2025 | $2.91 | $2.84 | 2.4% | |
| 30. September 2025 | $3.96 | $3.96 | -0.05% | |
| 30. Juni 2025 | $3.68 | $3.44 | 7.1% | |
| 31. März 2025 | $3.35 | $3.31 | 1.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B | $10.28B | $8.45B | |
| Cost of Revenue | $11.91B | $11.05B | $11.20B | $10.39B | $10.50B | $9.28B | $9.00B | $8.71B | $6.13B | $6.49B | $5.59B | $4.14B | |
| Gross Profit | · | · | · | · | · | $7.58B | $8.29B | $7.27B | $5.94B | $5.99B | $4.70B | $4.30B | |
| R&D Expense | $1.26B | $1.19B | $1.24B | $1.26B | $1.28B | $1.04B | $1.06B | $1.00B | $770M | $828M | $632M | $550M | |
| SG&A Expense | $5.28B | $4.86B | $4.72B | $4.71B | $4.72B | $4.18B | $4.33B | $4.02B | $2.91B | $3.00B | $2.56B | $2.15B | |
| Operating Expenses | $19.26B | $17.78B | $17.26B | $16.59B | $16.88B | $15.16B | $15.53B | $14.47B | $10.57B | $11.05B | $9.21B | $6.84B | |
| Operating Income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B | $912M | $1.76B | $1.51B | $1.52B | $1.43B | $1.07B | $1.61B | |
| Interest Expense | $613M | $528M | $452M | $398M | $469M | $528M | $639M | $706M | $521M | $388M | $371M | $135M | |
| Interest Income | $38M | $163M | $49M | $16M | $9M | $7M | $12M | $65M | $76M | $21M | $15M | $46M | |
| Other Non-op | $-123M | $-28M | $-46M | $-117M | $-99M | $23M | $43M | $305M | $-101M | $11M | $21M | $5M | |
| Pretax Income | $1.88B | $2.00B | $1.66B | $1.78B | $1.69B | $414M | $1.18B | $1.17B | $976M | $1.07B | $739M | $1.52B | |
| Income Tax | $203M | $300M | $132M | $148M | $88M | $62M | $-57M | $862M | $-124M | $97M | $44M | $337M | |
| Net Income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874M | $1.23B | $311M | $1.10B | $976M | $695M | $1.19B | |
| EPS (Basic) | $5.83 | $5.88 | $4.97 | $5.93 | $6.92 | $2.75 | $4.01 | $0.62 | $4.70 | $4.59 | $3.43 | $6.13 | |
| EPS (Diluted) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.94 | $0.60 | $4.60 | $4.49 | $3.35 | $5.99 | |
| Shares (Basic) | 287,648,000 | 289,763,000 | 286,282,000 | 285,005,000 | 289,288,000 | 278,971,000 | 269,943,000 | 258,354,000 | 218,943,000 | 212,702,000 | 202,537,000 | 193,299,000 | |
| Shares (Diluted) | 288,509,000 | 291,009,000 | 288,392,000 | 287,364,000 | 292,089,000 | 282,402,000 | 274,775,000 | 264,621,000 | 223,588,000 | 217,536,000 | 207,509,000 | 197,709,000 | |
| EBITDA | $5.04B | $4.68B | $4.40B | $4.51B | $5.07B | $3.64B | $4.01B | $3.48B | $2.57B | $2.54B | $1.97B | $2.17B |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $567M | $1.72B | $1.42B | $1.01B | $2.28B | $2.83B | $536M | $1.14B | $14.18B | $1.54B | $1.42B | $1.86B | |
| Receivables | $2.40B | $3.03B | $2.53B | $2.19B | $2.35B | $2.40B | $2.35B | $2.32B | $1.74B | $1.62B | $1.62B | $1.19B | |
| Inventory | $3.15B | $3.84B | $3.27B | $3.22B | $2.74B | $2.74B | $2.58B | $2.45B | $1.82B | $1.72B | $1.96B | $1.50B | |
| Other Current Assets | $1.38B | $1.29B | $1.38B | $1.56B | $1.05B | $891M | $1.12B | $1.25B | $871M | $480M | $563M | $698M | |
| Current Assets | $9.26B | $10.47B | $8.68B | $8.14B | $8.84B | $8.97B | $6.66B | $7.41B | $18.63B | $6.37B | $5.66B | $6.13B | |
| PP&E (Net) | $6.38B | $6.82B | $6.56B | $6.01B | $6.00B | $5.92B | $5.66B | $5.38B | $4.64B | $3.90B | $4.06B | $3.60B | |
| PP&E (Gross) | $13.66B | $14.38B | $13.58B | $12.41B | $12.09B | $11.92B | $11.13B | $10.48B | $9.39B | $8.42B | $8.28B | $7.76B | |
| Accum. Depreciation | $7.27B | $7.56B | $7.02B | $6.40B | $6.09B | $6.00B | $5.47B | $5.11B | $4.75B | $4.52B | $4.22B | $4.16B | |
| Goodwill | $25.96B | $26.46B | $24.52B | $24.62B | $23.89B | $23.60B | $23.38B | $23.60B | $7.56B | $7.42B | $7.54B | $1.09B | |
| Intangibles | $9.23B | $10.87B | $10.90B | $12.26B | $12.73B | $13.77B | · | · | · | · | · | · | |
| Other Non-current Assets | $2.38B | $2.62B | $2.08B | $1.85B | $1.95B | $1.69B | $1.09B | $1.08B | $1.01B | $824M | $717M | $488M | |
| Total Assets | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B | $54.01B | $51.77B | $53.90B | $37.73B | $25.59B | $26.48B | $12.38B | |
| Accounts Payable | $6.11B | $1.90B | $1.64B | $1.70B | $1.74B | $1.35B | $1.09B | $1.11B | $797M | $665M | $631M | $401M | |
| Accrued Liabilities | $3.10B | $3.48B | $2.60B | $2.60B | $2.87B | $2.64B | $2.13B | $2.25B | $1.39B | $1.57B | $1.62B | $1.05B | |
| Current Liabilities | $8.31B | $8.96B | $6.64B | $7.81B | $6.63B | $5.84B | $5.66B | $7.22B | $3.34B | $4.40B | $4.38B | $2.23B | |
| Capital Leases | $704M | $667M | $414M | $384M | $344M | $336M | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $1.95B | $130M | |
| Other Non-current Liabilities | $2.63B | $3.56B | $4.58B | $5.05B | $5.21B | $5.75B | $5.68B | $5.74B | $1.61B | $1.68B | $2.43B | $383M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $12.12B | $3.77B | |
| Total Debt | $17.62B | $17.94B | $14.74B | $13.89B | $17.11B | $17.22B | $18.08B | $18.89B | $18.67B | $10.55B | $12.12B | $3.77B | |
| Common Stock | $371M | $371M | $371M | $365M | $365M | $365M | $347M | $347M | $347M | $333M | $333M | $333M | |
| Retained Earnings | $16.62B | $16.14B | $15.54B | $15.16B | $13.83B | $12.79B | $12.91B | $12.60B | $13.11B | $12.73B | $12.31B | $12.11B | |
| Treasury Stock | $9.81B | $8.81B | $8.30B | $8.33B | $7.72B | $6.14B | $6.19B | $6.24B | $8.43B | $8.21B | $8.24B | $8.60B | |
| AOCI | $-1.90B | $-1.73B | $-1.55B | $-1.49B | $-2.09B | $-2.55B | $-2.28B | $-1.91B | $-1.72B | $-1.93B | $-1.74B | $-1.00B | |
| Stockholders' Equity | $25.39B | $25.89B | $25.80B | $25.28B | $23.68B | $23.77B | $21.08B | $20.99B | $12.95B | $7.63B | $7.16B | $5.05B | |
| Liabilities + Equity | $55.33B | $57.29B | $52.78B | $52.93B | $53.87B | $54.01B | $51.77B | $53.90B | $37.73B | $25.59B | $26.48B | $12.45B |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.46B | $2.29B | $2.29B | $2.23B | $2.23B | $2.12B | $2.25B | $1.98B | $1.09B | $1.11B | $891M | $562M | |
| Stock-based Comp | $258M | $247M | $259M | $233M | $229M | $236M | $261M | $322M | $174M | $196M | $166M | $113M | |
| Deferred Tax | $-474M | $-211M | $-622M | $-129M | $-280M | $-285M | $-633M | $-262M | $-74M | $-519M | $-274M | $-94M | |
| Amort. of Intangibles | $1.59B | $1.47B | $1.47B | $1.43B | $1.40B | $1.38B | $1.50B | $1.25B | $553M | $552M | $346M | $84M | |
| Restructuring | $275M | $387M | $239M | $123M | $44M | $84M | · | · | $85M | $526M | $271M | · | |
| Other Non-cash | $-494M | $-183M | $-419M | $-1.64B | $333M | $553M | $216M | $516M | $262M | $792M | $252M | $-20M | |
| Operating Cash Flow | $3.43B | $3.84B | $2.99B | $2.47B | $4.13B | $2.94B | $3.33B | $2.87B | $2.55B | $2.56B | $1.73B | $1.75B | |
| CapEx | $760M | $725M | $874M | $973M | $1.19B | $769M | $957M | $895M | $727M | $693M | $596M | $592M | |
| Investing Cash Flow | $-818M | $-5.51B | $-716M | · | $-1.88B | $-1.23B | $-741M | $-15.73B | $-883M | $-669M | $-8.32B | $-948M | |
| Debt Issued | $0 | $4.52B | $1.66B | $497M | $4.87B | $3.39B | $2.22B | $5.09B | $11.46B | $0 | $6.16B | $0 | |
| Net Debt Issued | $-1.79B | $3.38B | $-493M | $-308M | $-243M | $-1.27B | $-2.52B | $1.09B | $7.48B | $-752M | $6.16B | · | |
| Stock Repurchased | $1.00B | $500M | $0 | $500M | $1.75B | $0 | $0 | $0 | $220M | $0 | $0 | $400M | |
| Net Stock Activity | $-1.00B | $-500M | $0 | $-500M | $-1.75B | · | $0 | $0 | $-220M | $0 | $0 | $-400M | |
| Dividends Paid | $1.20B | $1.10B | $1.11B | $1.08B | $1.05B | $1.03B | $984M | $927M | $677M | $562M | $485M | $421M | |
| Financing Cash Flow | $-3.62B | $2.09B | $-1.96B | · | $-3.31B | $22M | $-3.22B | $-58M | $10.98B | $-1.76B | $6.19B | $-807M | |
| Net Change in Cash | $-1.00B | $375M | $322M | $-1.23B | $-525M | $2.33B | $-646M | $-12.94B | $12.64B | $117M | $-436M | $-29M | |
| Taxes Paid | $599M | $653M | $629M | $532M | $671M | $523M | $536M | $235M | $265M | $218M | $240M | $330M | |
| Free Cash Flow | $2.67B | $3.12B | $2.12B | $1.50B | $3.42B | $2.73B | $2.37B | $1.97B | $1.82B | $1.87B | $1.13B | $1.15B | |
| Levered FCF | $2.12B | $2.67B | $1.70B | $1.13B | $2.98B | $2.26B | $1.70B | $1.78B | $1.24B | $1.51B | $785M | $1.05B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 44.3% | 47.9% | 45.4% | 49.1% | 48.0% | 45.7% | · | |
| Operating Margin | 11.8% | 11.9% | 10.9% | 12.1% | 13.8% | 8.7% | 10.2% | 9.4% | 12.2% | 11.5% | 10.4% | 19.0% | |
| Net Margin | 7.7% | 8.5% | 7.7% | 9.4% | 10.3% | 5.1% | 7.1% | 1.9% | 9.1% | 7.8% | 6.8% | 14.0% | |
| Pretax Margin | 8.6% | 9.9% | 8.6% | 9.4% | 11.1% | 5.8% | 6.8% | 7.3% | 8.1% | 8.6% | 7.2% | 18.0% | |
| EBITDA Margin | 23.1% | 23.2% | 22.7% | 23.9% | 25.1% | 21.2% | 23.2% | 21.7% | 21.2% | 20.4% | 19.1% | 25.7% | |
| ROA | 3.0% | 3.1% | 2.8% | 3.3% | 3.9% | 1.7% | 2.3% | 0.68% | 3.5% | 3.8% | 3.5% | 9.6% | |
| ROE | 6.5% | 6.6% | 5.8% | 7.3% | 8.8% | 3.9% | 5.9% | 1.8% | 10.7% | 13.2% | 11.4% | 23.5% | |
| ROIC | 5.3% | 4.7% | 4.8% | 5.3% | 6.4% | 3.2% | 4.7% | 1.0% | 5.3% | 7.1% | 5.2% | 14.2% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.3 | 1.0 | 1.3 | 1.5 | 1.2 | 1.0 | 5.6 | 1.4 | 1.4 | 2.7 | |
| Quick Ratio | 0.4 | 0.5 | 0.6 | 0.4 | 0.7 | 0.9 | 0.5 | 0.5 | 4.8 | 0.7 | 0.7 | 1.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 | 0.7 | 0.9 | 0.9 | 1.4 | 1.4 | 1.7 | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 | 0.7 | 0.9 | 0.9 | 1.4 | 1.4 | 1.6 | 0.7 | |
| Interest Coverage | 4.2 | 4.5 | 4.7 | 5.7 | 6.0 | 2.8 | 2.8 | 2.1 | 2.8 | 3.7 | 2.9 | 11.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.7 | |
| Inventory Turnover | 3.1 | 3.1 | 3.4 | 3.5 | 3.9 | 3.6 | 3.6 | 4.1 | 3.5 | 3.5 | 3.2 | 2.9 | |
| Receivables Turnover | 7.2 | 7.2 | 8.2 | 8.3 | 8.3 | 7.2 | 7.4 | 7.9 | 7.2 | 7.7 | 7.3 | 7.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $75.70 | $69.34 | $67.17 | $65.67 | $69.32 | $60.61 | $62.92 | $60.40 | $54.09 | $57.38 | $49.55 | $42.72 | |
| Cash Flow / Share | $11.89 | $13.21 | $10.37 | $8.60 | $15.91 | $12.53 | $12.12 | $10.83 | $11.40 | $11.76 | $8.34 | $8.83 | |
| Dividend Paid / Share | $4.16 | $3.80 | $3.64 | $3.48 | $3.32 | $3.16 | $3.08 | $3.00 | $2.92 | $2.64 | $2.40 | $2.18 | |
| EPS (TTM) | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 | $2.71 | $3.94 | $0.60 | $4.60 | $4.49 | $3.35 | $5.99 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.2% | 4.2% | 2.7% | -1.4% | 19.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.0% | 1.8% | 6.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -0.68% | 18.6% | -16.0% | -14.2% | 152.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -0.34% | -5.1% | 22.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | 14.9% | -16.6% | -15.0% | 139.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.9% | -6.6% | 19.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 13.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 3.1% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B | $16.07B | $17.29B | $15.98B | $12.09B | $12.48B | $10.28B | $8.45B | |
| Net Income TTM | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B | $874M | $1.23B | $311M | $1.10B | $976M | $695M | $1.19B | |
| P/E | 25.3 | 32.3 | 41.1 | 29.8 | 27.5 | 65.9 | 49.2 | 333.6 | 32.7 | 30.7 | 30.4 | 14.6 | |
| Earnings Yield | 4.0% | 3.1% | 2.4% | 3.4% | 3.6% | 1.5% | 2.0% | 0.30% | 3.1% | 3.3% | 3.3% | 6.9% | |
| Payout Ratio | 71.3% | 64.5% | 75.1% | 60.8% | 50.1% | 117.4% | 79.8% | 298.1% | 61.6% | 57.6% | 69.8% | 35.5% | |
| Annual Payout | $1.20B | $1.10B | $1.11B | $1.08B | $1.05B | $1.03B | $984M | $927M | $677M | $562M | $485M | $421M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.98B | $4.71B | $5.25B | $5.89B | $4.73B | $4.48B | $5.17B | $5.44B | $4.99B | $5.04B | $4.71B | $5.09B | $4.88B | $4.82B | $4.59B | $4.76B | |
| Cost of Revenue | $2.67B | $2.56B | $2.84B | $3.09B | $2.49B | $2.62B | $2.93B | $2.95B | $2.68B | $2.74B | $2.68B | $3.38B | $2.78B | $2.59B | $2.45B | $2.68B | |
| R&D Expense | $258M | $249M | $306M | $323M | $230M | $232M | $343M | $302M | $299M | $299M | $290M | $281M | $306M | $337M | $313M | $300M | |
| SG&A Expense | $1.26B | $1.21B | $1.39B | $1.37B | $1.16B | $1.12B | $1.32B | $1.25B | $1.20B | $1.19B | $1.21B | $1.14B | $1.19B | $1.21B | $1.19B | $1.18B | |
| Operating Expenses | $4.32B | $4.62B | $4.70B | $5.19B | $3.99B | $4.10B | $4.71B | $4.81B | $4.39B | $4.31B | $4.27B | $4.74B | $4.33B | $4.19B | $4.00B | $4.27B | |
| Operating Income | $663M | $93M | $552M | $698M | $739M | $383M | $453M | $622M | $602M | $734M | $439M | $349M | $549M | $628M | $585M | $489M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $125M | $111M | $113M | $119M | $118M | $102M | $104M | |
| Interest Income | $4M | $9M | $4M | $5M | $4M | $5M | $23M | $55M | $48M | $26M | $34M | $9M | $24M | $10M | $6M | $7M | |
| Other Non-op | $19M | $86M | $-10M | $-36M | $-22M | $-36M | $-16M | $-9M | $-13M | $-2M | $-4M | $-63M | $17M | $8M | $-8M | $-73M | |
| Pretax Income | $554M | $39M | $393M | $509M | $569M | $201M | $306M | $513M | $500M | $633M | $359M | $181M | $471M | $529M | $481M | $320M | |
| Income Tax | $102M | $76M | $11M | $16M | $118M | $43M | $3M | $114M | $13M | $96M | $77M | $28M | $64M | $68M | $-28M | $33M | |
| Net Income | $377M | $-311M | $382M | $493M | $574M | $308M | $303M | $400M | $487M | $537M | $281M | $108M | $407M | $460M | $509M | $288M | |
| EPS (Basic) | $1.37 | $-1.11 | $1.34 | $1.71 | $2.00 | $1.07 | $1.05 | $1.38 | $1.68 | $1.85 | $0.97 | $0.35 | $1.37 | $1.54 | $1.71 | $0.94 | |
| EPS (Diluted) | $1.37 | $-1.11 | $1.34 | $1.71 | $2.00 | $1.07 | $1.04 | $1.37 | $1.68 | $1.85 | $0.96 | $0.35 | $1.36 | $1.53 | $1.70 | $0.92 | |
| Shares (Basic) | 274,788,000 | 280,640,000 | 285,582,000 | · | 287,170,000 | 287,293,000 | 289,505,000 | · | 289,562,000 | 289,518,000 | 290,113,000 | · | 286,317,000 | 284,292,000 | 283,887,000 | · | |
| Shares (Diluted) | 275,158,000 | 280,640,000 | 285,845,000 | · | 287,223,000 | 287,737,000 | 290,389,000 | · | 290,253,000 | 290,344,000 | 291,398,000 | · | 287,944,000 | 285,645,000 | 285,340,000 | · | |
| EBITDA | $1.23B | $656M | $1.17B | · | $882M | $546M | $1.06B | · | $602M | $734M | $1.00B | · | $549M | $628M | $1.15B | · |
Bilanz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $708M | $813M | $740M | $641M | $735M | $667M | $711M | $1.72B | $4.46B | $2.35B | $1.18B | · | $923M | $1.98B | $612M | · | |
| Receivables | $2.36B | $2.21B | $2.51B | $2.99B | $2.94B | $3.03B | $2.64B | $3.03B | $2.60B | $2.56B | $2.27B | · | $2.41B | $2.41B | $2.28B | · | |
| Inventory | $3.32B | $3.36B | $4.08B | $3.89B | $3.95B | $3.72B | $3.86B | $3.84B | $3.25B | $3.23B | $3.30B | · | $3.59B | $3.66B | $3.60B | · | |
| Other Current Assets | $1.59B | $1.43B | $1.56B | $1.51B | $1.28B | $1.15B | $1.33B | $1.29B | $1.02B | $1.33B | $1.35B | · | $1.28B | $1.44B | $1.54B | · | |
| Current Assets | $8.14B | $8.01B | $9.19B | $9.26B | $9.00B | $8.67B | $8.66B | $10.47B | $12.21B | $10.34B | $8.16B | · | $8.59B | $9.59B | $8.18B | · | |
| PP&E (Net) | $6.08B | $6.08B | $6.97B | $7.00B | $6.82B | $6.65B | $6.60B | $6.82B | $6.52B | $6.59B | $6.65B | · | $6.47B | $6.36B | $6.25B | · | |
| PP&E (Gross) | $13.60B | $13.55B | $15.24B | $15.11B | $14.85B | $14.41B | $14.16B | $14.38B | $13.92B | $13.93B | $13.90B | · | $13.47B | $13.20B | $12.93B | · | |
| Accum. Depreciation | $7.52B | $7.47B | $8.27B | $8.12B | $8.04B | $7.76B | $7.55B | $7.56B | $7.40B | $7.33B | $7.25B | · | $7.00B | $6.85B | $6.68B | · | |
| Goodwill | $25.94B | $25.95B | $26.62B | $26.61B | $26.60B | $26.44B | $26.33B | $26.46B | $24.55B | $24.57B | $24.60B | $24.52B | $24.58B | $24.78B | $24.76B | $24.62B | |
| Intangibles | $8.02B | $8.35B | $9.01B | $9.39B | $9.77B | $10.12B | $10.47B | $10.87B | $9.86B | $10.21B | $10.57B | · | $11.27B | $11.63B | $11.94B | · | |
| Other Non-current Assets | $2.55B | $2.43B | $3.04B | $3.06B | $2.70B | $2.58B | $2.59B | $2.62B | $2.40B | $2.40B | $2.26B | · | $2.06B | $1.99B | $1.96B | · | |
| Total Assets | $50.73B | $50.83B | $54.84B | $55.33B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B | $52.27B | · | $53.02B | $54.39B | $53.13B | · | |
| Accounts Payable | $6.11B | $5.93B | $6.14B | $1.97B | $6.35B | $6.09B | $6.35B | $1.90B | $5.41B | $5.31B | $5.52B | · | $5.02B | $5.09B | $5.44B | · | |
| Accrued Liabilities | · | · | · | $3.10B | · | · | · | $3.48B | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9.40B | $8.51B | $8.76B | $8.31B | $8.16B | $7.69B | $7.66B | $8.96B | $6.61B | $7.33B | $7.54B | · | $6.88B | $7.30B | $7.62B | · | |
| Capital Leases | · | · | · | $704M | · | · | · | $667M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.39B | $2.46B | $2.81B | $2.93B | $2.83B | $3.00B | $3.42B | $3.56B | $4.07B | $4.30B | $4.41B | · | $4.37B | $4.47B | $4.86B | · | |
| Total Debt | $13.51B | $14.71B | $16.92B | · | $17.53B | $17.67B | $17.44B | · | $18.13B | $15.99B | $14.09B | · | $14.93B | $16.01B | $14.27B | · | |
| Common Stock | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | $371M | · | $371M | $365M | $365M | · | |
| Retained Earnings | $17.51B | $17.39B | $16.70B | $16.62B | $16.43B | $16.15B | $16.14B | $16.14B | $16.02B | $15.80B | $15.54B | · | $15.69B | $15.56B | $15.38B | · | |
| Treasury Stock | $12.06B | $11.66B | $10.06B | $9.81B | $9.56B | $9.56B | $9.43B | $8.81B | $8.81B | $8.81B | $8.83B | · | $8.32B | $8.33B | $8.33B | · | |
| AOCI | $-1.65B | $-1.76B | $-1.86B | $-1.90B | $-1.81B | $-1.72B | $-1.68B | $-1.73B | $-1.58B | $-1.53B | $-1.51B | · | $-1.51B | $-1.57B | $-1.56B | $-1.49B | |
| Stockholders' Equity | $24.42B | $24.13B | $25.28B | $25.39B | $25.47B | $25.24B | $25.20B | $25.89B | $25.87B | $25.65B | $25.33B | · | $25.94B | $25.69B | $25.47B | · | |
| Liabilities + Equity | $50.73B | $50.83B | $54.84B | $55.33B | $54.90B | $54.47B | $54.66B | $57.29B | $55.58B | $54.16B | $52.27B | · | $53.02B | $54.39B | $53.13B | · |
Cashflow
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $564M | $563M | $614M | $629M | $575M | $567M | $607M | $586M | $568M | $571M | $561M | $587M | $571M | $563M | $567M | $581M | |
| Stock-based Comp | $55M | $58M | $91M | $55M | $54M | $59M | $90M | $51M | $53M | $60M | $83M | $58M | $56M | $56M | $89M | $49M | |
| Amort. of Intangibles | $365M | $380M | $397M | $398M | $388M | $387M | $395M | $375M | $362M | $366M | $365M | $367M | $367M | $366M | $365M | $366M | |
| Restructuring | $48M | $482M | $75M | $88M | $58M | $63M | $66M | $125M | $95M | $98M | $69M | $119M | $61M | $33M | $26M | $51M | |
| Other Non-cash | · | · | $-845M | · | · | · | $-677M | · | · | · | $82M | · | · | · | $-1.43B | · | |
| Operating Cash Flow | $776M | $671M | $657M | $1.35B | $1.22B | $164M | $693M | $1.18B | $1.30B | $514M | $855M | $1.32B | $1.08B | $185M | $399M | $973M | |
| CapEx | $143M | $125M | $108M | $352M | $174M | $129M | $105M | $296M | $179M | $134M | $116M | $294M | $191M | $181M | $208M | $315M | |
| Investing Cash Flow | · | · | $-183M | $-494M | $-336M | $-192M | $204M | $-3.94B | $-288M | $-1.06B | $-233M | $137M | $-329M | $-233M | $-291M | · | |
| Net Debt Issued | $-2.00B | $-2.00B | $0 | · | · | · | $-875M | · | · | · | $0 | · | · | · | $-528M | · | |
| Stock Repurchased | $0 | $2.00B | $250M | $250M | $0 | $0 | $750M | $0 | $0 | $0 | $500M | $0 | $0 | $0 | $0 | $500M | |
| Net Stock Activity | · | · | $-250M | · | · | · | $-750M | · | · | · | $-500M | · | · | · | · | · | |
| Dividends Paid | $286M | $290M | $299M | $297M | $299M | $298M | $302M | $275M | $275M | $275M | $275M | $265M | $286M | $282M | $281M | $270M | |
| Financing Cash Flow | · | · | $-302M | $-809M | $-841M | $-39M | $-1.93B | $124M | $1.12B | $1.71B | $-862M | $-997M | $-1.79B | $1.37B | $-534M | · | |
| Net Change in Cash | $-152M | $64M | $174M | $53M | $51M | $-66M | $-1.04B | $-2.63B | $2.09B | $1.16B | $-247M | $456M | $-1.04B | $1.32B | $-415M | $-1.60B | |
| Free Cash Flow | · | · | $549M | · | · | · | $588M | · | · | · | $739M | · | · | · | $191M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $652M | · | · | · | $83M | · |
Rentabilität
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.3% | 2.0% | 10.5% | · | 16.0% | 10.4% | 8.8% | · | 12.1% | 14.5% | 9.3% | · | 11.2% | 13.0% | 12.8% | · | |
| Net Margin | 7.6% | -6.6% | 7.3% | · | 10.4% | 5.8% | 5.9% | · | 9.8% | 10.6% | 6.0% | · | 8.3% | 9.5% | 11.1% | · | |
| Pretax Margin | 11.1% | 0.83% | 7.5% | · | 12.8% | 6.9% | 5.9% | · | 10.0% | 12.6% | 7.6% | · | 9.7% | 11.0% | 10.5% | · | |
| EBITDA Margin | 24.6% | 13.9% | 22.2% | · | 16.0% | 10.4% | 20.5% | · | 12.1% | 14.5% | 21.2% | · | 11.2% | 13.0% | 25.1% | · | |
| ROA | 0.71% | -0.59% | 0.70% | · | 1.0% | 0.57% | 0.57% | · | 0.90% | 0.99% | 0.53% | · | 0.77% | 0.84% | 0.96% | · | |
| ROE | 1.5% | -1.3% | 1.5% | · | 2.2% | 1.2% | 1.2% | · | 1.9% | 2.1% | 1.1% | · | 1.6% | 1.8% | 2.1% | · | |
| ROIC | 1.4% | -0.23% | 1.3% | · | 1.7% | 1.1% | 1.1% | · | 1.3% | 1.5% | 0.87% | · | 1.2% | 1.3% | 1.6% | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 1.0 | · | 1.1 | 1.1 | 1.1 | · | 1.8 | 1.4 | 1.1 | · | 1.2 | 1.3 | 1.1 | · | |
| Quick Ratio | 0.3 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 1.1 | 0.7 | 0.5 | · | 0.5 | 0.6 | 0.4 | · | |
| Debt / Equity | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | |
| LT Debt / Equity | 0.6 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.9 | 4.0 | · | 4.6 | 5.3 | 5.7 | · |
Effizienz
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.7 | · | |
| Receivables Turnover | 1.9 | 1.8 | 2.0 | · | 2.0 | 1.9 | 2.1 | · | 2.0 | 2.0 | 2.1 | · | 2.1 | 2.0 | 2.1 | · |
Pro Aktie
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $18.11 | $16.80 | $18.37 | · | $19.18 | $18.32 | $17.80 | · | $17.19 | $17.38 | $16.15 | · | $16.94 | $16.88 | $16.07 | · | |
| Cash Flow / Share | · | · | $2.30 | · | · | · | $2.39 | · | · | · | $2.93 | · | · | · | $1.40 | · | |
| Dividend / Share | $1.05 | $1.05 | $1.05 | · | $1.04 | $1.04 | $1.04 | · | $0.95 | $0.95 | $0.95 | · | $0.91 | $0.91 | $0.91 | · | |
| EPS (TTM) | $3.31 | $3.94 | $6.12 | · | $5.48 | $5.16 | $5.94 | · | $4.84 | $4.52 | $4.20 | · | $5.51 | $5.33 | $5.30 | · |
Bewertung (TTM)
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.84B | $20.58B | $20.35B | · | $19.81B | $20.07B | $20.64B | · | $19.83B | $19.72B | $19.49B | · | $19.05B | $18.81B | $18.74B | · | |
| Net Income TTM | $941M | $1.14B | $1.76B | · | $1.58B | $1.50B | $1.73B | · | $1.41B | $1.33B | $1.26B | · | $1.66B | $1.62B | $1.61B | · | |
| P/E | 45.7 | 39.9 | 24.9 | · | 24.7 | 34.9 | 30.0 | · | 38.0 | 43.0 | 45.6 | · | 37.7 | 36.5 | 37.7 | · | |
| Earnings Yield | 2.2% | 2.5% | 4.0% | · | 4.0% | 2.9% | 3.3% | · | 2.6% | 2.3% | 2.2% | · | 2.6% | 2.7% | 2.6% | · | |
| Payout Ratio | · | · | 78.3% | · | · | · | 99.7% | · | · | · | 97.9% | · | · | · | 55.2% | · | |
| Annual Payout | $1.17B | $1.19B | $1.19B | · | $1.17B | $1.15B | $1.13B | · | $1.09B | $1.10B | $1.11B | · | $1.12B | $1.10B | $1.09B | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Umsatz | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B |
| Betriebsgewinnmarge % | 11.8% | 11.9% | 10.9% | 12.1% | 13.8% |
| Nettoergebnis | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B |
| Verwässerte EPS | $5.82 | $5.86 | $4.94 | $5.88 | $6.85 |
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | 0.7 | 0.6 | 0.5 | 0.7 |
| Liquiditätsgrad | 1.1 | 1.2 | 1.3 | 1.0 | 1.3 |
| Quick Ratio | 0.4 | 0.5 | 0.6 | 0.4 | 0.7 |
| Kennzahl | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Freier Cashflow | $2.67B | $3.12B | $2.12B | $1.50B | $3.42B |
Institutionelle Eigentümer (13F) 1.551 Einreicher · $46.7B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
1.551
Gehaltener Wert
$46.7B
Neue Positionen
127
Geschlossene Positionen
141
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 127 (-30 vs. Vorquartal) | 141 (-45 vs. Vorquartal) | 547 (-18 vs. Vorquartal) | 547 (+12 vs. Vorquartal) | +9.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.118.281.692 | 36.678.939 | 15,23% | Aktien |
| BlackRock, Inc. | $3.721.532.551 | 24.592.166 | 7,96% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.722.098.919 | 17.987.834 | 5,83% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2.483.123.897 | 8.650.967 | 5,31% | Aktien |
| STATE STREET CORP | $2.269.959.685 | 15.000.064 | 4,86% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.266.036.001 | 14.974.136 | 4,85% | Aktien |
| First Eagle Investment Management, LLC | $2.090.674.677 | 13.815.335 | 4,47% | Aktien |
| Invesco Ltd. | $1.346.608.236 | 8.898.488 | 2,88% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.228.361.034 | 8.141.586 | 2,63% | Aktien |
| FRANKLIN RESOURCES INC | $1.061.064.151 | 7.011.592 | 2,27% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $962.154.023 | 6.357.986 | 2,06% | Aktien |
| GREENHAVEN ASSOCIATES INC | $859.812.872 | 5.681.708 | 1,84% | Aktien |
| NORGES BANK | $630.973.916 | 4.169.523 | 1,35% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $556.370.023 | 3.676.534 | 1,19% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $515.287.516 | 3.398.203 | 1,10% | Aktien |
| MORGAN STANLEY | $502.353.875 | 3.319.590 | 1,08% | Aktien |
| Clearbridge Investments, LLC | $489.222.504 | 3.232.819 | 1,05% | Aktien |
| BANK OF AMERICA CORP /DE/ | $474.992.547 | 3.138.786 | 1,02% | Aktien |
| JPMORGAN CHASE & CO | $440.071.112 | 2.835.692 | 0,94% | Aktien |
| NORTHERN TRUST CORP | $397.274.543 | 2.625.220 | 0,85% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $385.001.377 | 2.544.118 | 0,82% | Aktien |
| HARRIS ASSOCIATES L P | $355.771.231 | 2.350.963 | 0,76% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $324.096.377 | 2.141.003 | 0,69% | Aktien |
| First Pacific Advisors, LP | $319.426.456 | 2.110.794 | 0,68% | Aktien |
| Legal & General Group Plc | $318.049.508 | 2.101.695 | 0,68% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $296.900.554 | 1.888.320 | 0,64% | Aktien |
| Amundi | $274.921.665 | 1.816.703 | 0,59% | Aktien |
| GOLDMAN SACHS GROUP INC | $266.177.531 | 1.758.921 | 0,57% | Aktien |
| Longview Partners (Guernsey) LTD | $255.761.774 | 1.690.093 | 0,55% | Aktien |
| BRANDES INVESTMENT PARTNERS, LP | $252.955.949 | 1.671.540 | 0,54% | Aktien |
| Bank of New York Mellon Corp | $247.371.528 | 1.634.649 | 0,53% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $234.270.795 | 1.548.079 | 0,50% | Aktien |
| MACKENZIE FINANCIAL CORP | $216.917.330 | 1.433.406 | 0,46% | Aktien |
| Veritas Asset Management LLP | $210.852.478 | 1.393.329 | 0,45% | Aktien |
| DEUTSCHE BANK AG\ | $204.226.494 | 1.349.544 | 0,44% | Aktien |
| BARCLAYS PLC | $191.750.849 | 1.267.104 | 0,41% | Aktien |
| UBS Group AG | $183.686.019 | 1.213.811 | 0,39% | Aktien |
| WELLS FARGO & COMPANY/MN | $183.226.555 | 1.210.775 | 0,39% | Aktien |
| JARISLOWSKY, FRASER Ltd | $175.028.282 | 935.130 | 0,37% | Aktien |
| COOKE & BIELER LP | $171.990.480 | 1.136.526 | 0,37% | Aktien |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $167.650.789 | 1.107.849 | 0,36% | Aktien |
| ProShare Advisors LLC | $162.283.113 | 1.072.379 | 0,35% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $156.784.054 | 1.036.041 | 0,34% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $152.018.930 | 1.004.552 | 0,33% | Aktien |
| Focus Partners Wealth | $144.422.511 | 954.318 | 0,31% | Aktien |
| Findlay Park Partners LLP | $143.945.096 | 951.200 | 0,31% | Aktien |
| M&G PLC | $134.044.663 | 887.713 | 0,29% | Aktien |
| FIDUCIARY MANAGEMENT INC /WI/ | $125.873.419 | 831.781 | 0,27% | Aktien |
| Cullen Capital Management, LLC | $124.804.866 | 824.720 | 0,27% | Aktien |
| Swiss National Bank | $121.639.357 | 803.802 | 0,26% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter | 8. September 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 1. September 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 25. August 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 16. August 2006 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 14. August 2006 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 83 Insider · 47 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Thomas E Polen Jr | Chairman, CEO and President | 13. August 2026 M | 110.163 | 0 | 2 | $-1.172.631 |
| Vitor Roque | EVP & Chief Financial Officer | 2. September 2026 F | 8.041 | 0 | 0 | $0 |
| Christopher Delorefice | EVP & Chief Financial Officer | 26. November 2025 F | 22.982 | 0 | 0 | $0 |
| Christopher R Reidy | CFO and EVP of Administration | 26. November 2021 A | 31.524 | 0 | 0 | $0 |
| David V Elkins | Executive VP and CFO | 9. November 2012 D | 0 | 0 | 0 | $0 |
| Michael Feld | EVP, Chief Revenue Officer | 28. September 2026 S | 19.644 | 0 | 12 | $-170.822 |
| Roland Goette | EVP and President, EMEA | 11. August 2026 S | 14.856 | 0 | 1 | $-440.888 |
| Bilal Muhsin | EVP & President Connected Care | 2. Juli 2026 F | 41.359 | 0 | 0 | $0 |
| Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | 24. Juni 2026 S | 13.172 | 0 | 5 | $-784.162 |
| Peter Menziuso | EVP and President, BDI | 1. Juni 2026 A | 14.258 | 0 | 0 | $0 |
| Shana Carol Neal | EVP and Chief People Officer | 6. April 2026 F | 23.966 | 0 | 0 | $0 |
| Lanesha Minnix | EVP and General Counsel | 16. März 2026 A | 7.492 | 0 | 0 | $0 |
| Pamela L. Spikner | SVP Controller & CAO | 2. März 2026 A | 3.323 | 0 | 0 | $0 |
| David Shan | EVP and Chief ISC Officer | 3. Januar 2026 F | 8.926 | 0 | 0 | $0 |
| Richard Byrd | EVP & President Interventional | 26. November 2025 F | 13.849 | 0 | 0 | $0 |
| Pavan Kumar Mocherla | EVP & President, Greater Asia | 26. November 2025 A | 5.763 | 0 | 0 | $0 |
| Michelle Quinn | EVP and General Counsel | 26. November 2024 A | 6.927 | 0 | 0 | $0 |
| Antoine C Ezell | EVP, President Americas & CMO | 26. November 2024 A | 11.970 | 0 | 0 | $0 |
| Thomas J Spoerel | SVPController & Chief Acct Off | 1. Juli 2024 F | 1.928 | 0 | 0 | $0 |
| David Hickey | EVP & President, Life Sciences | 26. November 2023 A | 5.862 | 0 | 0 | $0 |
| Samrat S. Khichi | EVP and General Counsel | 21. Dezember 2022 G | 9.251 | 0 | 0 | $0 |
| Rishi Grover | EVP and Chief ISC Officer | 8. Juli 2022 A | 9.439 | 0 | 0 | $0 |
| James Lim | Executive Vice President | 17. Juni 2022 A | 23.941 | 0 | 0 | $0 |
| Betty D Larson | EVP HR & CHRO | 25. Februar 2022 M | 5.872 | 0 | 0 | $0 |
| Simon D Campion | EVP and Segment President | 11. Februar 2022 G | 10.319 | 0 | 0 | $0 |
| Alexandre Conroy | EVP of Integrated Supply Chain | 3. Februar 2022 M | 21.260 | 0 | 0 | $0 |
| Ribo Alberto Mas | EVP and Pres, Life Sciences | 26. November 2021 A | 11.662 | 0 | 0 | $0 |
| Vincent A Forlenza | Chairman of the Board | 15. Dezember 2020 G | 194.048 | 0 | 0 | $0 |
| Patrick Kaltenbach | EVP & Pres Life Sciences | 26. November 2020 A | 10.340 | 0 | 0 | $0 |
| Charles R Bodner | SVP Corp Fin Chief Acct Office | 6. September 2019 M | 2.037 | 0 | 0 | $0 |
| James W Borzi | EVP & Chief Supply Chain Offcr | 30. November 2018 M | 2.775 | 0 | 0 | $0 |
| William A Tozzi | EVP Pres Interventional | 2. Juli 2018 A | 12.830 | 0 | 0 | $0 |
| Nabil Shabshab | Executive Vice President | 11. Mai 2018 M | 7.811 | 0 | 0 | $0 |
| John E Gallagher | VP, Corp Finance and Treasurer | 2. März 2018 F | 1.975 | 0 | 0 | $0 |
| Linda M Tharby | Executive Vice President | 1. Februar 2018 M | 13.437 | 0 | 0 | $0 |
| John P Groetelaars | EVP | 2. Januar 2018 A | 42.508 | 0 | 0 | $0 |
| Ellen R Strahlman | Senior Vice President | 25. November 2017 F | 6.898 | 0 | 0 | $0 |
| Gary M Cohen | Executive Vice President | 11. September 2017 M | 71.770 | 0 | 0 | $0 |
| Stephen Sichak | Executive Vice President | 8. September 2017 M | 7.953 | 0 | 0 | $0 |
| Jeffrey S Sherman | Sr. VP and General Counsel | 25. Mai 2017 M | 22.094 | 0 | 0 | $0 |
| Jerome V Hurwitz | Executive Vice President | 6. Mai 2016 S | 3.027 | 0 | 0 | $0 |
| William A Kozy | Executive Vice President | 9. Dezember 2015 S | 68.823 | 0 | 0 | $0 |
| Joseph Mercurio | VP and Corporate Controller | 25. November 2014 A | 1.932 | 0 | 0 | $0 |
| Donna M Boles | Senior VP - Human Resources | 17. Mai 2013 M | 14.607 | 0 | 0 | $0 |
| Suketu Upadhyay | Senior VP and Controller | 20. November 2012 A | 3.525 | 0 | 0 | $0 |
| William E. Rhodes | Senior Vice President | 20. November 2012 A | 5.972 | 0 | 0 | $0 |
| Edward J Ludwig | Chairman | 20. März 2012 G | 95.188 | 0 | 0 | $0 |
| Carrie L Byington | Direktor | 6. August 2026 A | 5.018 | 0 | 0 | $0 |
| Robert Luther Huffines | Direktor | 6. August 2026 A | 1.279 | 0 | 0 | $0 |
| Bertram L Scott | Direktor | 18. Februar 2026 S | 36.763 | 0 | 2 | $-212.345 |
| Christopher Ian Montague Jones | Direktor | 4. Februar 2026 A | 24.304 | 0 | 0 | $0 |
| Joanne Waldstreicher | Direktor | 27. Januar 2026 A | 3.391 | 0 | 0 | $0 |
| Jacqueline Wright | Direktor | 27. Januar 2026 A | 1.279 | 0 | 0 | $0 |
| William M Brown | Direktor | 27. Januar 2026 A | 4.663 | 0 | 0 | $0 |
| Jeffrey William Henderson | Direktor | 27. Januar 2026 A | 9.143 | 0 | 0 | $0 |
| Gregory Hayes | Direktor | 27. Januar 2026 A | 7.159 | 0 | 0 | $0 |
| Andrew R Eckert | Direktor | 27. Januar 2026 A | 10.423 | 0 | 0 | $0 |
| Timothy M Ring | Direktor | 27. Januar 2026 A | 59.160 | 0 | 0 | $0 |
| Catherine M Burzik | Direktor | 28. Januar 2025 A | 14.264 | 0 | 0 | $0 |
| LARSEN MARSHALL O | Direktor | 24. Januar 2023 A | 28.919 | 0 | 0 | $0 |
| Claire Pomeroy | Direktor | 25. Januar 2022 A | 9.982 | 0 | 0 | $0 |
| David F Melcher | Direktor | 25. Januar 2022 A | 6.180 | 0 | 0 | $0 |
| Rebecca W Rimel | Direktor | 8. September 2021 S | 10.618 | 0 | 0 | $0 |
| Gary A Mecklenburg | Direktor | 6. November 2018 A | 25.453 | 0 | 0 | $0 |
| Wilard J Overlock JR | Direktor | 6. November 2018 A | 19.442 | 0 | 0 | $0 |
| James F Orr | Direktor | 24. Januar 2017 A | 24.257 | 0 | 0 | $0 |
| Basil Anderson | Direktor | 26. Januar 2016 A | 22.596 | 0 | 0 | $0 |
| Henry P Becton JR | Direktor | 3. November 2015 A | 112.683 | 0 | 0 | $0 |
| Edward Degraan | Direktor | 27. Januar 2015 A | 22.416 | 0 | 0 | $0 |
| Alfred Sommer | Direktor | 28. Januar 2014 A | 20.689 | 0 | 0 | $0 |
| Adel Mahmoud | Direktor | 29. Januar 2013 A | 13.746 | 0 | 0 | $0 |
| Claire Fraser | · | 10. September 2025 S | 22.226 | 0 | 0 | $0 |
| David T Durack | · | 28. April 2011 M | 8.908 | 0 | 0 | $0 |
| Cathy E. Minehan | · | 1. Februar 2011 A | 8.535 | 0 | 0 | $0 |
| Scott P Bruder | · | 23. November 2010 A | 7.626 | 0 | 0 | $0 |
| Patricia B Shrader | · | 23. November 2010 A | 11.250 | 0 | 0 | $0 |
| John R Considine | · | 24. November 2009 A | 93.438 | 0 | 0 | $0 |
| Alfred John Hanson | · | 25. November 2008 A | 46.146 | 0 | 0 | $0 |
| James E Perrella | · | 31. Oktober 2007 A | 18.520 | 0 | 0 | $0 |
| Margeretha Af Ugglas | · | 31. Januar 2007 A | 15.920 | 0 | 0 | $0 |
| Jean Marc Dageville | · | 8. Dezember 2004 M | 4.658 | 0 | 0 | $0 |
| Harry N Beaty | · | 3. Mai 2004 M | 9.204 | 0 | 0 | $0 |
| OLSON FRANK ALBERT | · | 11. Februar 2004 A | 21.200 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 145 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 5,24% | 943.719 SH | 11. September 2026 | Täglich |
| CZA · Invesco Exchange-Traded Fund Trust | 2,47% | 23.309 SH | 1. Oktober 2026 | Täglich |
| EQTY · Valued Advisers Trust | 2,14% | 184.537 NS | 31. Juli 2026 | N-PORT |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,00% | 12.776 SH | 1. Oktober 2026 | Täglich |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,63% | 79.420 SH | 1. Oktober 2026 | Täglich |
| EPOL · iShares Trust | 1,60% | 69.343 SH | 11. September 2026 | Täglich |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,49% | 94.088 NS | 31. Juli 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,49% | 317.073 NS | 31. Juli 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,01% | 1.134.820 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,81% | 166.236 SH | 11. September 2026 | Täglich |
| RGEF · Tidal Trust III | 0,73% | 35.725 NS | 31. Juli 2026 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0,72% | 1.769.988 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,68% | 135.578 NS | 31. Juli 2026 | N-PORT |
| IMCV · iShares Trust | 0,68% | 44.851 SH | 11. September 2026 | Täglich |
| REVS · Columbia ETF Trust I | 0,65% | 13.100 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,64% | 856.811 SH | 19. August 2026 | Täglich |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,62% | 6.797 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 0,62% | 144.713 SH | 11. September 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,52% | 5.422 NS | 31. Juli 2026 | N-PORT |
| IWS · iShares Trust | 0,49% | 424.696 SH | 11. September 2026 | Täglich |
| EQIN · Columbia ETF Trust I | 0,48% | 8.836 NS | 31. Juli 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,42% | 148.656 NS | 31. Juli 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,41% | 35.456 NS | 31. Juli 2026 | N-PORT |
| DIVB · iShares Trust | 0,40% | 46.677 SH | 11. September 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,40% | 5.971.067 SH | 19. August 2026 | Täglich |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,39% | 17.954.000 | 1. Oktober 2026 | Täglich |
| HUSV · First Trust Exchange-Traded Fund III | 0,38% | 1.706 NS | 31. Juli 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,38% | 31.777 NS | 31. Juli 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,37% | 10.309 SH | 19. August 2026 | Täglich |
| IWR · iShares Trust | 0,37% | 1.164.966 SH | 11. September 2026 | Täglich |
| VLUE · iShares Trust | 0,36% | 194.404 SH | 11. September 2026 | Täglich |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,35% | 9.750 NS | 31. Juli 2026 | N-PORT |
| IMCB · iShares Trust | 0,34% | 32.267 SH | 11. September 2026 | Täglich |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 9.256 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,33% | 18.654 SH | 19. August 2026 | Täglich |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,30% | 27.935 NS | 31. Juli 2026 | N-PORT |
| DGRO · iShares Trust | 0,29% | 717.789 SH | 11. September 2026 | Täglich |
| XOEF · iShares Trust | 0,27% | 347 SH | 11. September 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,26% | 104.844 NS | 31. Juli 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 5.494 SH | 11. September 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1.087.905 SH | 1. Oktober 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,20% | 10.832 SH | 1. Oktober 2026 | Täglich |
| EUSA · iShares, Inc. | 0,19% | 20.800 SH | 11. September 2026 | Täglich |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,19% | 1.919 NS | 31. Juli 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,19% | 5.597.000 | 1. Oktober 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,18% | 171.825 NS | 31. Juli 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,18% | 6.482.000 | 1. Oktober 2026 | Täglich |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,18% | 255.000 | 1. Oktober 2026 | Täglich |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,18% | 1.556.657 SH | 19. August 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,18% | 1.134.690 SH | 19. August 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,18% | 7.746 SH | 1. Oktober 2026 | Täglich |
| FEUS · FlexShares Trust | 0,17% | 1.155 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,16% | 457.195 SH | 11. September 2026 | Täglich |
| VTV · VANGUARD INDEX FUNDS | 0,16% | 2.617.912 SH | 19. August 2026 | Täglich |
| IUSV · iShares Trust | 0,15% | 240.462 SH | 11. September 2026 | Täglich |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,15% | 4.447.000 | 1. Oktober 2026 | Täglich |
| ILCV · iShares Trust | 0,14% | 10.712 SH | 11. September 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,14% | 63.464 SH | 19. August 2026 | Täglich |
| EMGF · iShares, Inc. | 0,14% | 14.306 SH | 10. September 2026 | Täglich |
| DSI · iShares Trust | 0,14% | 42.114 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,14% | 632.304 SH | 11. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,13% | 68.767 SH | 1. Oktober 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,12% | 171.632 SH | 19. August 2026 | Täglich |
| GLBL · Pacer Funds Trust | 0,12% | 8 NS | 31. Juli 2026 | N-PORT |
| DFVX · Dimensional ETF Trust | 0,12% | 3.749 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,11% | 57.778 SH | 1. Oktober 2026 | Täglich |
| ESG · FlexShares Trust | 0,11% | 840 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,10% | 9.319 SH | 1. Oktober 2026 | Täglich |
| HDUS · Lattice Strategies Trust | 0,10% | 1.192 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 4.277 SH | 1. Oktober 2026 | Täglich |
| TOPC · iShares Trust | 0,09% | 171 SH | 11. September 2026 | Täglich |
| ACVF · ETF Opportunities Trust | 0,09% | 795 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,08% | 244.485 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,08% | 3.163 SH | 11. September 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,08% | 1.621 SH | 1. Oktober 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,07% | 47.593 SH | 1. Oktober 2026 | Täglich |
| IVV · iShares Trust | 0,07% | 3.473.127 SH | 11. September 2026 | Täglich |
| CRBN · iShares Trust | 0,07% | 4.897 SH | 11. September 2026 | Täglich |
| ILCB · iShares Trust | 0,07% | 5.340 SH | 11. September 2026 | Täglich |
| BKLC · BNY Mellon ETF Trust | 0,07% | 24.016 NS | 31. Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,07% | 197.581 SH | 11. September 2026 | Täglich |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 38.024 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,07% | 13.955 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,07% | 53.117 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,07% | 4.662 NS | 31. Juli 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0,07% | 321.801 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,07% | 64.270 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,07% | 1.117 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,07% | 11.794 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,07% | 2.283 NS | 31. Juli 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,07% | 24 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,07% | 78.106 SH | 11. September 2026 | Täglich |
| USCL · iShares Trust | 0,07% | 10.939 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,07% | 359.241 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,07% | 83.341 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,07% | 1.039 NS | 31. Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,06% | 6.630 NS | 31. Juli 2026 | N-PORT |
| LRGF · iShares Trust | 0,06% | 13.430 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,06% | 215 SH | 1. Oktober 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,06% | 7.153.108 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,06% | 8.748.767 SH | 19. August 2026 | Täglich |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,06% | 47.858 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,06% | 47.190 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,06% | 23.933 SH | 19. August 2026 | Täglich |
| TOK · iShares Trust | 0,06% | 795 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,06% | 11.787 NS | 31. Juli 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,06% | 1.923 NS | 31. Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,06% | 25.569 SH | 11. September 2026 | Täglich |
| JFLI · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 156 NS | 31. Juli 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,05% | 21.539 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,05% | 6.952 NS | 31. Juli 2026 | N-PORT |
| LDEM · iShares Trust | 0,05% | 91 SH | 11. September 2026 | Täglich |
| ACWI · iShares Trust | 0,05% | 94.438 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,05% | 6.917 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 11.593 SH | 1. Oktober 2026 | Täglich |
| EMXF · iShares Trust | 0,04% | 384 SH | 11. September 2026 | Täglich |
| ROUS · Lattice Strategies Trust | 0,04% | 1.753 NS | 31. Juli 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,04% | 247.589 SH | 19. August 2026 | Täglich |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,04% | 796 SH | 30. September 2026 | Täglich |
| GLOF · iShares Trust | 0,04% | 380 SH | 11. September 2026 | Täglich |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 1.792 NS | 31. Juli 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,02% | 33.336 SH | 11. September 2026 | Täglich |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 30.768 SH | 19. August 2026 | Täglich |
| EEM · iShares, Inc. | 0,02% | 31.606 SH | 10. September 2026 | Täglich |
| IEMG · iShares, Inc. | 0,02% | 152.904 SH | 10. September 2026 | Täglich |
| LGDX · Tidal Trust III | 0,01% | 113 NS | 31. Juli 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 186.147 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 125.091 SH | 19. August 2026 | Täglich |
| VSGX · VANGUARD WORLD FUND | 0,01% | 2.529 SH | 19. August 2026 | Täglich |
| AQLT · iShares Trust | 0,01% | 158 SH | 10. September 2026 | Täglich |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31. Juli 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 3.911 SH | 10. September 2026 | Täglich |
| IXUS · iShares Trust | 0,01% | 18.527 SH | 11. September 2026 | Täglich |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15. Juli 2026 | Täglich |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30. Juli 2026 | Täglich |
| BNDX · VANGUARD CHARLOTTE FUNDS | · | · | 15. Juli 2026 | Täglich |
| VCEB · VANGUARD WORLD FUND | · | · | 30. Juli 2026 | Täglich |
BDX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 21 Analysten
KAUF
Median-Ziel
$197.50
+11,7%
5 23,8%
Starker Kauf
7 33,3%
Kauf
9 42,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-10-01Mittelwert-Ziel $195.67 +10,7%
Jetzt
Aktueller Preis $176.80
Tief$170.00
Mittelwert$195.67
Hoch$225.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait”
Yahoo Finance · 3 Monate, 3 Wochen vor
Ist die Wall Street gegenüber der Becton, Dickinson and Company Aktie bullisch oder bärisch?
Yahoo Finance · 4 Monate, 1 Woche vor
Becton Dickinson (BDX) liefert solide Q2-Leistung, Barclays hebt Ziel an
Yahoo Finance · 4 Monate, 2 Wochen vor
Jim Cramer über Becton, Dickinson: „Das Unternehmen zeigte durchweg eine ausgezeichnete Leistung“
Yahoo Finance · 4 Monate, 3 Wochen vor
Becton, Dickinson and Company Q2 Earnings Call Highlights
Yahoo Finance · 4 Monate, 3 Wochen vor
RBC kürzt die Prognose für Becton Dickinson (BDX) trotz stabiler MedTech-Nachfrage
Yahoo Finance · 5 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026